State Street Corporation 13D and 13G filings for Sage Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-18 11:37 am Sale |
2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE |
STATE STREET CORP STT |
2,926,239 4.800% |
-991,983 (-25.32%) |
Filing |
| 2024-01-24 10:04 am Purchase |
2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
STATE STREET CORP STT |
3,918,222 6.530% |
3,918,222 (New Position) |
Filing |